title: [Advantages of different dosages of active metabolites in the follow-up of azathioprine treatment for Crohn disease].
authors: Département de médecine de l'enfant et de l'adolescent, CHU-Hôpital-Sud, 16, boulevard de Bulgarie, 35056 Rennes 02, France.
authors: B
authors: B
authors: Cagnard
authors: D
authors: D
authors: Tosoni-Verlingue
authors: O
authors: O
authors: Tribut
authors: C
authors: C
authors: Moizard
authors: L
authors: L
authors: Bridoux-Henno
authors: N
authors: N
authors: Delaperriere
authors: D
authors: D
authors: Bentue-Ferrer
authors: A
authors: A
authors: Dabadie
mesh_terms: D000293:Adolescent; D001379:Azathioprine / Q000008:administration & dosage* / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006150:Guanine Nucleotides / Q000378:metabolism*; D006801:Humans; D008297:Male; D013873:Thionucleotides / Q000378:metabolism*
chemical_list: D006150:Guanine Nucleotides; D013873:Thionucleotides; C003964:6-thioguanylic acid; D001379:Azathioprine